Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Complex karyotypic evolution in B-cell chronic lymphocytic leukemia.

P E Crossen¹, S M Tully, M J Morrison

¹Cytogenetic and Molecular Oncology Unit, Christchurch Hospital, New Zealand.

Cancer Genetics and Cytogenetics

|December 1, 1991

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Selection of test locations for regional trials of barley.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013

Same author

Inverse acyl phosph(on)ates: substrates or inhibitors of beta-lactam-recognizing enzymes?

Bioorganic chemistry·2005

Same author

Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis.

Internal medicine journal·2002

Same author

A full-length and potentially active LINE element is integrated polymorphically within the IGL locus in a genomically unstable region of chromosome 22.

Human genetics·2002

Same author

Translocation (2;14) associated with complex rearrangements of the Ig heavy chain in non-Hodgkin lymphoma.

Cancer genetics and cytogenetics·2001

Same author

Autologous PBSCT in patients with cardiac amyloidosis.

Bone marrow transplantation·2000

Same journal

Letter to the editor regarding the article "Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenic and prognostic implications".

Cancer genetics and cytogenetics·2010

Same journal

A novel t(10;12)(q21;p13) involving ETV6 in a patient with acute myeloid leukemia.

Cancer genetics and cytogenetics·2010

Same journal

A case of acute myeloid leukemia initially treated as chronic lymphocytic leukemia: what do we know about t(4;12)(q12;p13)?

Cancer genetics and cytogenetics·2010

Same journal

Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma.

Cancer genetics and cytogenetics·2010

Same journal

Chromosomal imbalances in urinary bladder paraganglioma.

Cancer genetics and cytogenetics·2010

Same journal

A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.

Cancer genetics and cytogenetics·2010

See all related articles

This study tracked chromosomal abnormalities in chronic B-cell leukemia, revealing evolving clones and the utility of combined cytogenetic and immunoglobulin gene studies for monitoring disease.

Area of Science:

Hematology
Oncology
Genetics

Background:

Chronic B-cell leukemia (B-CLL) is a lymphoid malignancy characterized by the accumulation of malignant B lymphocytes.
Understanding the genetic landscape and clonal evolution in B-CLL is crucial for prognosis and treatment.

Observation:

A female patient with B-CLL initially presented with a 4p+ chromosomal abnormality.
Over 4.5 years, six additional clones emerged, exhibiting complex chromosomal changes including 3p+, 4p-, and 11q- abnormalities.
Immunoglobulin heavy chain (IgH) gene rearrangement studies initially showed evidence of clonal expansion, which shifted towards a germline configuration post-splenectomy.

Findings:

Cytogenetic analysis revealed a dynamic clonal evolution in the B-CLL patient, with multiple subclones developing from the initial abnormal clone.

Related Experiment Videos

Discordance between cytogenetic and IgH gene rearrangement findings post-splenectomy highlighted the sensitivity of each method in detecting different cell populations.

Cytogenetic studies confirmed the persistence of abnormal clones despite changes in IgH gene rearrangement patterns.

Implications:

The combined use of cytogenetic and Ig gene rearrangement analyses offers a comprehensive approach to monitor minimal residual disease in B-CLL.
This integrated methodology provides detailed insights into the dynamics of normal and leukemic cell populations.
Accurate monitoring of clonal evolution and disease burden is essential for optimizing therapeutic strategies in chronic B-cell leukemia.